Explore: United States
City Therapeutics
🇺🇸Cambridge, United States
Next-generation RNAi startup founded by former Alnylam executives developing clinical-stage RNAi medicines. City Therapeutics is a deeptech and healthtech startup based in Cambridge, United States, founded 2024, with $99.5M raised to date.
City Therapeutics is tracked live on Scout, Fusion42's database of newly funded startups, where founders watch who is raising, who is backing whom, and where their market is moving.
Sectors
Geographies
Total raised
$99.5M
Founded
2024
Model
transactional
Investors
ARCH Venture Partners, Fidelity Management & Research Company, Invus, Slate Path Capital, Rock Springs Capital, Regeneron Ventures, AN Ventures
🔒 Valuation & traction
Sign in to view🔒 Full round history
Sign in to view🔒 Team
Sign in to viewSign in to see City Therapeutics's full profile
Valuation signals, web traffic, full round history and team. Free account, Google sign-in.
Create free accountFrequently asked questions
- What does City Therapeutics do?
- Next-generation RNAi startup founded by former Alnylam executives developing clinical-stage RNAi medicines.
- Where is City Therapeutics based?
- City Therapeutics is based in Cambridge, United States, founded in 2024.
- How much has City Therapeutics raised?
- City Therapeutics has raised $99.5M in tracked funding.
- Who has invested in City Therapeutics?
- Investors in City Therapeutics include ARCH Venture Partners, Fidelity Management & Research Company, Invus, Slate Path Capital, Rock Springs Capital, Regeneron Ventures and AN Ventures.